Valuation: DexCom, Inc.

Market Cap 31.49B 27.37B 25.48B 23.39B 44.18B 3,006B 44.86B 300B 118B 1,497B 118B 116B 5,018B P/E 2026 *
33.8x
P/E 2027 * 28.3x
Enterprise Value 31.2B 27.13B 25.25B 23.18B 43.78B 2,979B 44.45B 298B 117B 1,483B 117B 115B 4,973B EV / Sales 2026 *
5.97x
EV / Sales 2027 * 5.19x
Free-Float
92.53%
Yield 2026 *
-
Yield 2027 * -
1 week+14.94%
1 month+22.73%
3 months+51.64%
6 months+17.04%
Current year+26.62%
1 week 62.99
Extreme 62.99
73.4
1 month 58.66
Extreme 58.66
73.4
3 years 46.85
Extreme 46.85
132
5 years 46.85
Extreme 46.85
144.8
Manager TitleAgeSince
Chief Executive Officer 47 31/12/2025
Director of Finance/CFO 46 18/03/2021
Chief Tech/Sci/R&D Officer - 30/04/2024
Director TitleAgeSince
Chairman 68 29/07/2018
Director/Board Member 67 19/11/2009
Director/Board Member 47 31/12/2025
Change 5-day change 1-year change 3-year change Capi.($)
+6.27%+14.94%+2.38%-36.08% 31.49B
+0.09%+2.56%-16.96%-4.37% 183B
-0.37%+2.62%-4.42%-2.61% 109B
-0.29%+0.47%+7.97%+64.64% 60.57B
+3.50%+0.47%+41.00%+46.44% 51.8B
+0.10%+5.92%-6.10%-40.54% 45.64B
+0.41%+1.37% - - 33.22B
+0.40%+3.89%+42.51%-8.26% 24B
-1.22%+6.69%+0.67%+1.96% 22.26B
-3.79%+7.37%-9.34%-0.68% 21.51B
Average -0.13%+3.83%+6.41%+2.28% 61.24B
Weighted average by Cap. +0.11%+2.89%-0.63%+3.79%

Financials

2026 *2027 *
Net sales 5.23B 4.55B 4.23B 3.89B 7.34B 499B 7.45B 49.88B 19.58B 249B 19.64B 19.21B 833B 5.81B 5.05B 4.7B 4.32B 8.16B 555B 8.28B 55.46B 21.77B 276B 21.84B 21.36B 927B
Net income 961M 835M 777M 714M 1.35B 91.71B 1.37B 9.16B 3.6B 45.66B 3.61B 3.53B 153B 1.16B 1.01B 942M 865M 1.63B 111B 1.66B 11.11B 4.36B 55.36B 4.37B 4.28B 186B
Net Debt -286M -249M -232M -213M -401M -27.31B -408M -2.73B -1.07B -13.6B -1.07B -1.05B -45.6B -1.29B -1.12B -1.05B -960M -1.81B -123B -1.84B -12.32B -4.84B -61.39B -4.85B -4.74B -206B
Logo DexCom, Inc.
DexCom, Inc. specializes in the design, manufacture and marketing of continuous glucose monitoring (CGM) systems for people with diabetes and healthcare providers. The company provides an implantable device for continuous measurement of blood glucose levels and an external transmitter to which the sensor transmits glucose levels at specified intervals. The United States accounts for 71.5% of net sales.
Employees
-
Date Price Change
31/07/26 €72.40 +6.27%
30/07/26 €68.13 +3.94%
29/07/26 €65.55 -0.70%
28/07/26 €66.01 +2.18%
27/07/26 €64.60 +2.56%
Trader
Investor
Global
Quality
ESG MSCI
BBB
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
28
Last Close Price
83.45USD
Average target price
92.80USD
Spread / Average Target
+11.20%

Quarterly revenue - Rate of surprise